[1]
|
Agostinis, P., Berg, K., Cengel, K. A., Foster, T. H., Girotti, A. W., Gollnick, S. O. et al. (2011). Photodynamic Therapy of Cancer: An Update. CA: A Cancer Journal for Clinicians, 61, 250-281. https://doi.org/10.3322/caac.20114
|
[2]
|
Allegra, S., Cusato, J., De Nicolo, A., Boglione, L., Gatto, A., Cariti, G. et al. (2015). Role of Pharmacogenetic in Ribavirin Outcome Prediction and Pharmacokinetics in an Italian Cohort of HCV-1 and 4 Patients. Biomedicine & Pharmacotherapy, 69, 47-55.
https://doi.org/10.1016/j.biopha.2014.10.030
|
[3]
|
Ampuero, J., & Romero-Gómez, M. (2016). Pharmacogenetics of Ribavirin-Induced Anemia in Hepatitis C. Pharmacogenomics, 17, 1587-1594.
https://doi.org/10.2217/pgs.16.28
|
[4]
|
Baptista, M. S., Cadet, J., Di Mascio, P., Ghogare, A. A., Greer, A., Hamblin, M. R. et al. (2017). Type I and Type II Photosensitized Oxidation Reactions: Guidelines and Mechanistic Pathways. Photochemistry and Photobiology, 93, 912-919.
https://doi.org/10.1111/php.12716
|
[5]
|
Belouzard, S., Millet, J. K., Licitra, B. N., & Whittaker, G. R. (2012). Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein. Viruses, 4, 1011-1033.
https://doi.org/10.3390/v4061011
|
[6]
|
Boluki, E., Kazemian, H., Peeridogaheh, H., Alikhani, M. Y., Shahabi, S., Beytollahi, L., & Ghorbanzadeh, R. (2017). Antimicrobial Activity of Photodynamic Therapy in Combination with Colistin against a Pan-Drug Resistant Acinetobacter baumannii Isolated from Burn Patient. Photodiagnosis and Photodynamic Therapy, 18, 1-5.
https://doi.org/10.1016/j.pdpdt.2017.01.003
|
[7]
|
Boluki, E., Pourhajibagher, M., & Bahador, A. (2020). The Combination of Antimicrobial Photocatalysis and Antimicrobial Photodynamic Therapy to Eradicate the Extensively Drug-Resistant Colistin Resistant Acinetobacter baumannii. Photodiagnosis and Photodynamic Therapy, 31, Article ID: 101816.
https://doi.org/10.1016/j.pdpdt.2020.101816
|
[8]
|
Bullard-Feibelman, K. M., Govero, J., Zhu, Z., Salazar, V., Veselinovic, M., Diamond, M. S., & Geiss, B. J. (2017). The FDA-Approved Drug Sofosbuvir Inhibits Zika Virus Infection. Antiviral Research, 137, 134-140.
https://doi.org/10.1016/j.antiviral.2016.11.023
|
[9]
|
Cai, Q., Yang, M., Liu, D., Chen, J., Shu, D., Xia, J. et al. (2020). Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study. Engineering, 6, 1192-1198. https://doi.org/10.1016/j.eng.2020.03.007
|
[10]
|
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G. et al. (2020). A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. New England Journal of Medicine, 382, 1787-1799. https://doi.org/10.1056/NEJMoa2001282
|
[11]
|
Chawla, D., Chirla, D., Dalwai, S., Deorari, A. K., Ganatra, A., Gandhi, A. et al. (2020). Perinatal-Neonatal Management of COVID-19 Infection—Guidelines of the Federation of Obstetric and Gynaecological Societies of India (FOGSI), National Neonatology Forum of India (NNF), and Indian Academy of Pediatrics (IAP). Indian Pediatrics, 57, 536-548. https://doi.org/10.1007/s13312-020-1852-4
|
[12]
|
Chen, L., Liu, W., Zhang, Q., Xu, K., Ye, G., Wu, W. et al. (2020). RNA Based mNGS Approach Identifies a Novel Human Coronavirus from Two Individual Pneumonia Cases in 2019 Wuhan Outbreak. Emerging microbes & Infections, 9, 313-319.
https://doi.org/10.1080/22221751.2020.1725399
|
[13]
|
Cho, C. H., Lee, C. K., Nam, M. H., Yoon, S. Y., Lim, C. S., Cho, Y., & Kim, Y. K. (2014). Evaluation of the AdvanSure Real-Time RT-PCR Compared with Culture and Seeplex RV15 for Simultaneous Detection of Respiratory Viruses. Diagnostic Microbiology and Infectious Disease, 79, 14-18. https://doi.org/10.1016/j.diagmicrobio.2014.01.016
|
[14]
|
Cleemput, S., Dumon, W., Fonseca, V., Abdool Karim, W., Giovanetti, M., Alcantara, L. C. et al. (2020). Genome Detective Coronavirus Typing Tool for Rapid Identification and Characterization of Novel Coronavirus Genomes. Bioinformatics, 36, 3552-3555.
https://doi.org/10.1093/bioinformatics/btaa145
|
[15]
|
Cojocaru, F. D., Botezat, D., Gardikiotis, I., Uritu, C. M., Dodi, G., Trandafir, L. et al (2020). Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers. Pharmaceutics, 12, Article No. 171.
https://doi.org/10.3390/pharmaceutics12020171
|
[16]
|
Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M. (2020). The Cytokine Storm in COVID-19: An Overview of the Involvement of the Chemokine/Chemokine-Receptor System. Cytokine & Growth Factor Reviews, 53, 25-32.
https://doi.org/10.1016/j.cytogfr.2020.05.003
|
[17]
|
Corbett, A. H., Lim, M. L., & Kashuba, A. D. (2002). Kaletra (Lopinavir/Ritonavir). Annals of Pharmacotherapy, 36, 1193-1203. https://doi.org/10.1345/aph.1A363
|
[18]
|
Cunningham, A. C., Goh, H. P., & Koh, D. (2020). Treatment of COVID-19: Old Tricks for New Challenges. Critical Care, 24, Article No. 91.
https://doi.org/10.1186/s13054-020-2818-6
|
[19]
|
Cusato, J., De Nicolò, A., Boglione, L., Favata, F., Ariaudo, A., Mornese Pinna, S. et al. (2018). Pharmacogenetics of the Anti-HCV Drug Sofosbuvir: A Preliminary Study. Journal of Antimicrobial Chemotherapy, 73, 1659-1664.
https://doi.org/10.1093/jac/dky053
|
[20]
|
Dai, W. C., Zhang, H. W., Yu, J., Xu, H. J., Chen, H., Luo, S. P. et al. (2020). CT imaging and Differential Diagnosis of COVID-19. Canadian Association of Radiologists Journal, 71, 195-200. https://doi.org/10.1177/0846537120913033
|
[21]
|
Dara, M., & Talebzadeh, M. (2020). CRISPR/Cas as a Potential Diagnosis Technique for COVID-19. Avicenna Journal of Medical Biotechnology, 12, 201-202.
|
[22]
|
de Vries, R., Stell, A., Mohammed, S., Hermanns, C., Martinez, A. H., Jetten, M., & van Apeldoorn, A. (2020). Bioengineering, Biomaterials, and β-Cell Replacement Therapy. In G. Orlando, L. Piemonti, R. W. G. Gruessner et al. (Eds.), Piemonti, Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas (Vol. 2, pp. 461-486). Cambridge, MA: Academic Press. https://doi.org/10.1016/B978-0-12-814831-0.00033-6
|
[23]
|
Deng, M., Sun, W., Hu, J., Mei, L., Weng, D., Liu, B., & Xu, H. (2020). Radiological Features on HRCT and RT-PCR Testing for the Diagnosis of Coronavirus Disease 2019 (COVID-19) in China: A Comparative Study of 78 Cases in Pregnant Women. Preprint. https://doi.org/10.21203/rs.3.rs-23565/v1
|
[24]
|
Devaux, C. A., Rolain, J. M., Colson, P., & Raoult, D. (2020). New Insights on the Antiviral Effects of Chloroquine against Coronavirus: What to Expect for COVID-19? International Journal of Antimicrobial Agents, 55, Article ID: 105938.
https://doi.org/10.1016/j.ijantimicag.2020.105938
|
[25]
|
Du, Y. X., & Chen, X. P. (2020). Favipiravir: Pharmacokinetics and Concerns about Clinical Trials for 2019-nCoV Infection. Clinical Pharmacology & Therapeutics, 108, 242-247. https://doi.org/10.1002/cpt.1844
|
[26]
|
e Silva, L. F. D. C., & de Carvalho, M. S. N. (2020). Optical Techniques for Fast Screening-towards Prevention of the Coronavirus COVID-19 Outbreak. Photodiagnosis and Photodynamic Therapy,30, Article ID: 101765.
|
[27]
|
Elfiky, A. A. (2020). Anti-HCV, Nucleotide Inhibitors, Repurposing against COVID-19. Life Sciences, 248, Article ID: 117477. https://doi.org/10.1016/j.lfs.2020.117477
|
[28]
|
Elfiky, A., Gawad, W., & Elshemey, W. (2016). Hepatitis C Viral Polymerase Inhibition Using Directly Acting Antivirals, a Computational Approach. Software and Techniques for Bio-Molecular Modeling, 13, 197.
|
[29]
|
Fekrazad, R. (2020). Photobiomodulation and Antiviral Photodynamic Therapy as a Possible Novel Approach in COVID-19 Management. Photobiomodulation, Photomedicine, and Laser Surgery, 38, 255-257. https://doi.org/10.1089/photob.2020.4868
|
[30]
|
Gane, E. J., Stedman, C. A., Hyland, R. H., Ding, X., Svarovskaia, E., Symonds, W. T. et al. (2013). Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C. New England Journal of Medicine, 368, 34-44.
https://doi.org/10.1056/NEJMoa1208953
|
[31]
|
Ganguly, P., Byrne, C., Breen, A., & Pillai, S. C. (2018). Antimicrobial Activity of Photocatalysts: Fundamentals, Mechanisms, Kinetics and Recent Advances. Applied Catalysis B: Environmental, 225, 51-75. https://doi.org/10.1016/j.apcatb.2017.11.018
|
[32]
|
Girotti, A. W. (2001). Photosensitized Oxidation of Membrane Lipids: Reaction Pathways, Cytotoxic Effects, and Cytoprotective Mechanisms. Journal of Photochemistry and Photobiology B: Biology, 63, 103-113.
https://doi.org/10.1016/S1011-1344(01)00207-X
|
[33]
|
Gorbalenya, A. E., Baker, S. C., Baric, R., Groot, R. J. D., Drosten, C., Gulyaeva, A. A. et al. (2020). Severe Acute Respiratory Syndrome-Related Coronavirus: The Species and Its Viruses—A Statement of the Coronavirus Study Group. bioRxiv.
https://doi.org/10.1101/2020.02.07.937862
|
[34]
|
Gribble, J., Stevens, L. J., Agostini, M. L., Anderson-Daniels, J., Chappell, J. D., Lu, X. et al (2021). The Coronavirus Proofreading Exoribonuclease Mediates Extensive Viral Recombination. PLoS Pathogens, 17, e1009226.
https://doi.org/10.1371/journal.ppat.1009226
|
[35]
|
Gupta, S. K., Rosenkranz, S. L., Cramer, Y. S., Koletar, S. L., Szczech, L. A., Amorosa, V., & Hall, S. D. (2008). The Pharmacokinetics and Pharmacogenomics of Efavirenz and Lopinavir/Ritonavir in HIV-Infected Persons Requiring Hemodialysis. AIDS, 22, 1919-1927. https://doi.org/10.1097/QAD.0b013e32830e011f
|
[36]
|
Ison, M. G., Wolfe, C., & Boucher, H. W. (2020). Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process. JAMA, 323, 2365-2366.
https://doi.org/10.1001/jama.2020.8863
|
[37]
|
Kerry, R. G., Malik, S., Redda, Y. T., Sahoo, S., Patra, J. K., & Majhi, S. (2019). Nano-Based Approach to Combat Emerging Viral (NIPAH Virus) Infection. Nanomedicine: Nanotechnology, Biology and Medicine, 18, 196-220.
https://doi.org/10.1016/j.nano.2019.03.004
|
[38]
|
Khalili, J. S., Zhu, H., Mak, N. S. A., Yan, Y., & Zhu, Y. (2020). Novel Coronavirus Treatment with Ribavirin: Groundwork for an Evaluation Concerning COVID-19. Journal of Medical Virology, 92, 740-746. https://doi.org/10.1002/jmv.25798
|
[39]
|
Kohlrausch, F. B., de Cássia Estrela, R., Barroso, P. F., & Suarez-Kurtz, G. (2010). The Impact of SLCO1B1 Polymorphisms on the Plasma Concentration of Lopinavir and Ritonavir in HIV-Infected Men. British Journal of Clinical Pharmacology, 69, 95-98.
https://doi.org/10.1111/j.1365-2125.2009.03551.x
|
[40]
|
Lajoie, J., Mwangi, L., & Fowke, K. R. (2017). Preventing HIV Infection without Targeting the Virus: How Reducing HIV Target Cells at the Genital Tract Is a New Approach to HIV Prevention. AIDS Research and Therapy, 14, Article No. 46.
https://doi.org/10.1186/s12981-017-0166-7
|
[41]
|
Lam, A. M., Espiritu, C., Bansal, S., Steuer, H. M. M., Niu, C., Zennou, V. et al. (2012). Genotype and Subtype Profiling of PSI-7977 as a Nucleotide Inhibitor of Hepatitis C Virus. Antimicrobial Agents and Chemotherapy, 56, 3359-3368.
https://doi.org/10.1128/AAC.00054-12
|
[42]
|
LeMieux, J. (2020). COVID-19 Drives CRISPR Diagnostics: CRISPR’s Role in DNA Detection, Not Editing, May Fill the Gap in COVID-19 Testing. Genetic Engineering & Biotechnology News, 40, 21-22, 24, 25. https://doi.org/10.1089/gen.40.05.07
|
[43]
|
Letko, M. C., & Munster, V. (2020). Functional Assessment of Cell Entry and Receptor Usage for Lineage B β-Coronaviruses, Including 2019-nCoV. bioRxiv.
https://doi.org/10.1101/2020.01.22.915660
|
[44]
|
Li, B., Si, H. R., Zhu, Y., Yang, X. L., Anderson, D. E., Shi, Z. L. et al. (2020). Discovery of Bat Coronaviruses through Surveillance and Probe Capture-Based Next-Generation Sequencing. Msphere, 5, e00807-e00819. https://doi.org/10.1128/mSphere.00807-19
|
[45]
|
Li, H., Liu, S. M., Yu, X. H., Tang, S. L., & Tang, C. K. (2020). Coronavirus Disease 2019 (COVID-19): Current Status and Future Perspectives. International Journal of Antimicrobial Agents, 55, Article ID: 105951.
https://doi.org/10.1016/j.ijantimicag.2020.105951
|
[46]
|
Li, X., Geng, M., Peng, Y., Meng, L., & Lu, S. (2020). Molecular Immune Pathogenesis and Diagnosis of COVID-19. Journal of Pharmaceutical Analysis, 10, 102-108.
https://doi.org/10.1016/j.jpha.2020.03.001
|
[47]
|
Lim, J., Jeon, S., Shin, H. Y., Kim, M. J., Seong, Y. M., Lee, W. J. et al. (2020). Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: The Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR. Journal of Korean Medical Science, 35, e89. https://doi.org/10.3346/jkms.2020.35.e89
|
[48]
|
Liu, J., Zheng, X., Tong, Q., Li, W., Wang, B., Sutter, K. et al. (2020). Overlapping and Discrete Aspects of the Pathology and Pathogenesis of the Emerging Human Pathogenic Coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. Journal of Medical Virology, 92, 491-494. https://doi.org/10.1002/jmv.25709
|
[49]
|
Liu, Y., Gayle, A. A., Wilder-Smith, A., & Rocklov, J. (2020). The Reproductive Number of COVID-19 Is Higher Compared to SARS Coronavirus. Journal of Travel Medicine, 27, taaa021. https://doi.org/10.1093/jtm/taaa021
|
[50]
|
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R. et al. (2001). Peginterferon Alfa-2b Plus Ribavirin Compared with Interferon Alfa-2b Plus Ribavirin for Initial Treatment of Chronic Hepatitis C: A Randomised Trial. Lancet, 358, 958-965. https://doi.org/10.1016/S0140-6736(01)06102-5
|
[51]
|
Moshfegh, F., Khosraviani, F., Moghaddasi, N., Limoodi, S. F. S. J., & Boluki, E. (2021). Antiviral Optical Techniques as a Possible Novel Approach to COVID-19 Treatment. Journal of Innovative Optical Health Sciences, Article ID: 2130002.
https://doi.org/10.1142/S1793545821300020
|
[52]
|
Nasir, J. A., Speicher, D. J., Kozak, R. A., Poinar, H. N., Miller, M. S., & McArthur, A. G. (2020). Rapid Design of a Bait Capture Platform for Culture-and Amplification-Free Next-Generation Sequencing of SARS-CoV-2. Preprints, Article No. 385.
https://doi.org/10.20944/preprints202002.0385.v1
|
[53]
|
Nguyen, T., Duong Bang, D., & Wolff, A. (2020). 2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics. Micromachines, 11, 306. https://doi.org/10.3390/mi11030306
|
[54]
|
Palmeira, V. A., Costa, L. B., Perez, L. G., Ribeiro, V. T., & Lanza, K. (2020). Do We Have Enough Evidence to Use Chloroquine/Hydroxychloroquine as a Public Health Panacea for COVID-19? Clinics, 75, e1928. https://doi.org/10.6061/clinics/2020/e1928
|
[55]
|
Pan, Y., Li, X., Yang, G., Fan, J., Tang, Y., Zhao, J. et al. (2020). Serological Immunochromatographic Approach in Diagnosis with SARS-CoV-2 Infected COVID-19 Patients. Journal of Infection, 81, e28-e32. https://doi.org/10.1016/j.jinf.2020.03.051
|
[56]
|
Pang, J., Chia, P. Y., Lye, D. C., & Leo, Y. S. (2017). Progress and Challenges towards Point-of-Care Diagnostic Development for Dengue. Journal of Clinical Microbiology, 55, 3339-3349. https://doi.org/10.1128/JCM.00707-17
|
[57]
|
Phan, T. (2020). Novel Coronavirus: From Discovery to Clinical Diagnostics. Infection, Genetics and Evolution, 79, Article ID: 104211.
https://doi.org/10.1016/j.meegid.2020.104211
|
[58]
|
Pourhajibagher, M., Boluki, E., Chiniforush, N., Pourakbari, B., Farshadzadeh, Z., Ghorbanzadeh, R. et al. (2016). Modulation of Virulence in Acinetobacter baumannii Cells Surviving Photodynamic Treatment with Toluidine Blue. Photodiagnosis and Photodynamic Therapy, 15, 202-212. https://doi.org/10.1016/j.pdpdt.2016.07.007
|
[59]
|
Razonable, R. R. (2011). Antiviral Drugs for Viruses Other than Human Immunodeficiency Virus. Mayo Clinic Proceedings, 86, 1009-1026.
https://doi.org/10.4065/mcp.2011.0309
|
[60]
|
Reuter, J. A., Spacek, D. V., & Snyder, M. P. (2015). High-Throughput Sequencing Technologies. Molecular Cell, 58, 586-597. https://doi.org/10.1016/j.molcel.2015.05.004
|
[61]
|
Rismanbaf, A. (2020). Potential Treatments for COVID-19; A Narrative Literature Review. Archives of Academic Emergency Medicine, 8, 2-4.
|
[62]
|
Shen, C., Wang, Z., Zhao, F., Yang, Y., Li, J., Yuan, J. et al. (2020). Treatment of 5 Critically Ill Patients with COVID-19 with Convalescent Plasma. JAMA, 323, 1582-1589.
https://doi.org/10.1001/jama.2020.4783
|
[63]
|
Sung, H., Yoo, C. K., Han, M. G., Lee, S. W., Lee, H., Chun, S. et al. (2020). Preparedness and Rapid Implementation of External Quality Assessment Helped Quickly Increase COVID-19 Testing Capacity in the Republic of Korea. Clinical Chemistry, 66, 979-981.
https://doi.org/10.1093/clinchem/hvaa097
|
[64]
|
Taylor, J. B. (2007). Comprehensive Medicinal Chemistry II. Amsterdam: Elsevier.
|
[65]
|
Tebaldi, M. L., Belardi, R. M., & Montoro, S. R. (2016). Polymers with Nano-Encapsulated Functional Polymers: Encapsulated Phase Change Materials. In S. Thomas, R. Shanks, & S. Chandrasekharakurup (Eds.), Design and Applications of Nanostructured Polymer Blends and Nanocomposite Systems (pp. 155-169). Amsterdam: Elsevier.
https://doi.org/10.1016/B978-0-323-39408-6.00019-4
|
[66]
|
Udugama, B., Kadhiresan, P., Kozlowski, H. N., Malekjahani, A., Osborne, M., Li, V. Y. et al. (2020). Diagnosing COVID-19: The Disease and Tools for Detection. ACS Nano, 14, 3822-3835. https://doi.org/10.1021/acsnano.0c02624
|
[67]
|
Vellingiri, B., Jayaramayya, K., Iyer, M., Narayanasamy, A., Govindasamy, V., Giridharan, B. et al. (2020). COVID-19: A Promising Cure for the Global Panic. Science of the Total Environment, 725, Article ID: 138277.
https://doi.org/10.1016/j.scitotenv.2020.138277
|
[68]
|
Vickers, N. J. (2017). Animal Communication: When I’m Calling you, Will You Answer Too? Current Biology, 27, R713-R715. https://doi.org/10.1016/j.cub.2017.05.064
|
[69]
|
Wan, S., Xiang, Y., Fang, W., Zheng, Y., Li, B., Hu, Y. et al. (2020). Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing. Journal of Medical Virology, 92, 797-806. https://doi.org/10.1002/jmv.25783
|
[70]
|
Wang, L., Wang, Y., Ye, D., & Liu, Q. (2020). A Review of the 2019 Novel Coronavirus (COVID-19) Based on Current Evidence. International Journal of Antimicrobial Agents, 55, Article ID: 105948. https://doi.org/10.1016/j.ijantimicag.2020.106137
|
[71]
|
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M. et al. (2020). Remdesivir and Chloroquine Effectively Inhibit the Recently Emerged Novel Coronavirus (2019-nCoV) in Vitro. Cell Research, 30, 269-271. https://doi.org/10.1038/s41422-020-0282-0
|
[72]
|
Wang, Y., Kang, H., Liu, X., & Tong, Z. (2020). Combination of RT-qPCR Testing and Clinical Features for Diagnosis of COVID-19 Facilitates Management of SARS-CoV-2 Outbreak. Journal of Medical Virology, 92, 538-539. https://doi.org/10.1002/jmv.25721
|
[73]
|
Warren, T. K., Jordan, R., Lo, M. K., Ray, A. S., Mackman, R. L., Soloveva, V. et al. (2016). Therapeutic Efficacy of the Small Molecule GS-5734 against Ebola Virus in Rhesus Monkeys. Nature, 531, 381-385. https://doi.org/10.1038/nature17180
|
[74]
|
Wiehe, A., O’Brien, J. M., & Senge, M. O. (2019). Trends and Targets in Antiviral Phototherapy. Photochemical & Photobiological Sciences, 18, 2565-2612.
https://doi.org/10.1039/C9PP00211A
|
[75]
|
Winzeler, E. A. (2008). Malaria Research in the Post-Genomic Era. Nature, 455, 751-756.
https://doi.org/10.1038/nature07361
|
[76]
|
Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y. et al. (2020). Analysis of Therapeutic Targets for SARS-CoV-2 and Discovery of Potential Drugs by Computational Methods. Acta Pharmaceutica Sinica B, 10, 766-788.
https://doi.org/10.1016/j.apsb.2020.02.008
|
[77]
|
Xiang, J., Yan, M., Li, H., Liu, T., Lin, C., Huang, S., & Shen, C. (2020). Evaluation of Enzyme-Linked Immunoassay and Colloidal Gold-Immunochromatographic Assay Kit for Detection of Novel Coronavirus (SARS-Cov-2) Causing an Outbreak of Pneumonia (COVID-19). MedRxiv. https://doi.org/10.1101/2020.02.27.20028787
|
[78]
|
Xiao, Y., Peng, Z., Tan, C., Meng, X., Huang, X., Wu, A., & Li, C. (2020). Diagnostic Options for Coronavirus Disease 2019 (COVID-19). Infection Control & Hospital Epidemiology, 41, 1358-1359. https://doi.org/10.1017/ice.2020.168
|
[79]
|
Xiu, L., Binder, R. A., Alarja, N. A., Kochek, K., Coleman, K. K., Than, S. T. et al. (2020). A RT-PCR Assay for the Detection of Coronaviruses from Four Genera. Journal of Clinical Virology, 128, Article ID: 104391. https://doi.org/10.1016/j.jcv.2020.104391
|
[80]
|
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C. et al. (2020). Pathological Findings of COVID-19 Associated with Acute Respiratory Distress Syndrome. The Lancet Respiratory Medicine, 8, 420-422. https://doi.org/10.1016/S2213-2600(20)30076-X
|
[81]
|
Ye, Q., Wang, B., & Mao, J. (2020). The Pathogenesis and Treatment of the ‘Cytokine Storm’ in COVID-19. Journal of Infection, 80, 607-613.
https://doi.org/10.1016/j.jinf.2020.03.037
|
[82]
|
Yuen, K. S., Ye, Z. W., Fung, S. Y., Chan, C. P., & Jin, D. Y. (2020). SARS-CoV-2 and COVID-19: The Most Important Research questions. Cell & Bioscience, 10, Article No. 40. https://doi.org/10.1186/s13578-020-00404-4
|
[83]
|
Zeng, F., Li, L., Zeng, J., Deng, Y., Huang, H., Chen, B., & Deng, G. (2020). Can We Predict the Severity of Coronavirus Disease 2019 with a Routine Blood Test? Polish Archives of Internal Medicine, 130, 400-406. https://doi.org/10.20452/pamw.15331
|
[84]
|
Zhang, W., Zhao, Y., Zhang, F., Wang, Q., Li, T., Liu, Z. et al. (2020). The Use of Anti-Inflammatory Drugs in the Treatment of People with Severe Coronavirus Disease 2019 (COVID-19): The Perspectives of Clinical Immunologists from China. Clinical Immunology, 214, Article ID: 108393. https://doi.org/10.1016/j.clim.2020.108393
|
[85]
|
Zheng, M., & Song, L. (2020). Novel Antibody Epitopes Dominate the Antigenicity of Spike Glycoprotein in SARS-CoV-2 Compared to SARS-CoV. Cellular & Molecular Immunology, 17, 536-538. https://doi.org/10.1038/s41423-020-0385-z
|
[86]
|
Zhou, P., Yang, X. L., Wang, X. G., Hu, B., Zhang, L., Zhang, W. et al. (2020). Discovery of a Novel Coronavirus Associated with the Recent Pneumonia Outbreak in Humans and Its Potential Bat Origin. BioRxiv. https://doi.org/10.1101/2020.01.22.914952
|
[87]
|
Zhu, H., Rhee, J. W., Cheng, P., Waliany, S., Chang, A., Witteles, R. M. et al. (2020). Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response. Current Cardiology Reports, 22, Article No. 36.
https://doi.org/10.1007/s11886-020-01302-4
|